But for a long time China’s people struggled to get hold of Wegovy because the country’s regulators had not approved it. Some ...
Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...
Health Canada has approved Novo Nordisk’s semaglutide injection, Wegovy, to reduce the risk of non-fatal myocardial ...
Canada's health regulator has approved Novo Nordisk's weight-loss drug Wegovy to reduce the risk of nonfatal heart attack or ...
The biggest threat for European pharmaceutical groups currently comes from the United States. President-elect Donald Trump ...
Amgen's experimental weight loss injection, MariTide, showed up to 20% weight loss in patients without diabetes and 17% in ...
Diabetologist and Consultant Endocrinologist at the College of Medicine, University of Lagos and Lagos University Teaching Hospital, ...
It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.
Novo Nordisk shifts its recruitment focus to China, expanding operations to meet rising demand for Ozempic and Wegovy in the ...